Summation Bio
Somerville
About Summation Bio
Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology. The company was founded in 2018 and is headquartered in Somerville, Massachusetts, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $24.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2022)
- Phone: 617-863-3650
Industries & Categories
Biotechnology, Genetics, Therapeutics
Canonical: https://fsome.com/organization/summation-bio-64951 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.